Skip to main content
Premium Trial:

Request an Annual Quote

Decode Genetics' Stock to be Suspended on Nasdaq Tomorrow

NEW YORK (GenomeWeb News) – Decode Genetics has received notification from the Nasdaq Stock Market that the firm's common stock will be suspended from trading as of the open of business tomorrow.

The Iceland-based firm also said that documents will be filed with the US Securities and Exchange Commission, which will remove the firm's common stock from listing on Nasdaq.

Decode said that it is possible its stock will be traded thereafter on the Pink Sheets, but that depends if there is a market maker for the shares.

The firm received a delisting notice from Nasdaq in November, following its filing for Chapter 11 bankruptcy protection.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.